Treatment of (ASS1)-negative GBM with ADI-PEG20, an inhibitor of arginase 1 (Arg1), was shown to be effective, whereas ASS1-positive GBM cells were unaffected by ADI-PEG20. Here, ASS1 is linked to glioblastoma.